Literature DB >> 27565227

Cone Integrity in Glaucoma: An Adaptive-Optics Scanning Laser Ophthalmoscopy Study.

Tomoko Hasegawa1, Sotaro Ooto2, Kohei Takayama1, Yukiko Makiyama1, Tadamichi Akagi1, Hanako O Ikeda1, Hideo Nakanishi1, Kenji Suda1, Hiroshi Yamada1, Akihito Uji1, Nagahisa Yoshimura1.   

Abstract

PURPOSE: To investigate photoreceptor changes in eyes with glaucoma.
DESIGN: Cross-sectional study.
METHODS: The study included 35 eyes of 35 patients with primary open-angle glaucoma who had suffered parafoveal visual field loss at least 3 years previously, as well as 21 eyes of 21 normal subjects. Eyes with an axial length ≥26.0 mm were excluded. All subjects underwent a full ophthalmologic examination, including spectral-domain optical coherence tomography (SDOCT) and prototype adaptive-optics scanning laser ophthalmoscopy (AO-SLO) imaging.
RESULTS: As determined using AO-SLO, eyes with glaucoma did not differ significantly from normal eyes in terms of either cone density (26 468 ± 3392 cones/m2 vs 26 147 ± 2700 cones/m2, respectively; P = .77; measured 0.5 mm from the foveal center) or cone spatial organization (ratio of hexagonal Voronoi domain: 43.7% ± 4.4% vs 44.3% ± 4.9%; P = .76; measured 0.5 mm from the foveal center). Furthermore, SDOCT showed that the 2 groups did not differ significantly in terms of the photoreceptor-related layer thickness, and that the photoreceptor ellipsoid zone band was continuous in all normal and glaucoma eyes. In glaucoma eyes with vertically asymmetric severity, the more affected side did not significantly differ from the less affected side in terms of cone density, cone spatial organization, or photoreceptor-related layer thickness. In 8 eyes (22.9%) with glaucoma, dark, partition-like areas surrounded the cones on the AO-SLO.
CONCLUSIONS: Both AO-SLO and SDOCT showed cone integrity in eyes with glaucoma, even in areas with visual field and nerve fiber loss. In AO-SLO, microcystic lesions in the inner nuclear layer may influence images of the cone mosaic.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27565227     DOI: 10.1016/j.ajo.2016.08.021

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Protruded retinal layers within the optic nerve head neuroretinal rim.

Authors:  Lucas A Torres; Jayme R Vianna; Faisal Jarrar; Glen P Sharpe; Makoto Araie; Joseph Caprioli; Shaban Demirel; Christopher A Girkin; Masanori Hangai; Aiko Iwase; Jeffrey M Liebmann; Christian Y Mardin; Toru Nakazawa; Harry A Quigley; Alexander F Scheuerle; Kazuhisa Sugiyama; Hidenobu Tanihara; Goji Tomita; Yasuo Yanagi; Claude F Burgoyne; Balwantray C Chauhan
Journal:  Acta Ophthalmol       Date:  2018-06       Impact factor: 3.761

Review 2.  Adaptive optics: principles and applications in ophthalmology.

Authors:  Engin Akyol; Ahmed M Hagag; Sobha Sivaprasad; Andrew J Lotery
Journal:  Eye (Lond)       Date:  2020-11-30       Impact factor: 3.775

Review 3.  Retinal vasculature in glaucoma: a review.

Authors:  Karen K W Chan; Fangyao Tang; Clement C Y Tham; Alvin L Young; Carol Y Cheung
Journal:  BMJ Open Ophthalmol       Date:  2017-07-11

4.  Expansion of retinal nerve fiber bundle narrowing in glaucoma: An adaptive optics scanning laser ophthalmoscopy study.

Authors:  Tomoko Hasegawa; Sotaro Ooto; Tadamichi Akagi; Takanori Kameda; Hideo Nakanishi; Hanako Ohashi Ikeda; Kenji Suda; Akitaka Tsujikawa
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-04

5.  Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model.

Authors:  Maximilian Weiss; Sabrina Reinehr; Ana M Mueller-Buehl; Johanna D Doerner; Rudolf Fuchshofer; Gesa Stute; H Burkhard Dick; Stephanie C Joachim
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

6.  Quantification of Retinal Ganglion Cell Morphology in Human Glaucomatous Eyes.

Authors:  Zhuolin Liu; Osamah Saeedi; Furu Zhang; Ricardo Villanueva; Samuel Asanad; Anant Agrawal; Daniel X Hammer
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.